PFKFB3 and breast cancer: In lung adenocarcinoma cells, levels of PFKFB3 were downregulated after PFK15 treatment, and upregulated expression of PFKFB3 in breast cancer tissues assessed by immunohistochemistry was found to be associated with poor patient prognosis [27].